Gene-expression profiles in human nasal polyp tissues and identification of genetic susceptibility in aspirin-intolerant asthma

Clinical and Experimental Allergy

Volumn 39, Issue 7, 2009, Pages 972-981

  Sekigawa, T ^a,b   Tajima, A ^a   Hasegawa, T ^b   Hasegawa, Y ^c   Inoue, H ^d   Sano, Y ^e   Matsune, S ^f   Kurono, Y ^f   Inoue, I ^a,g  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e Doai Memorial Hospital   (Japan)

^f KAGOSHIMA UNIVERSITY   (Japan)

^g JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Aspirin intolerant asthma; Candidate genes; Genetic association; Genome wide gene expression; Single nucleotide polymorphism

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; ASPIRIN INTOLERANT ASTHMA; ASTHMA; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; MALE; NOSE POLYP; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALGORITHMS; ARTIFICIAL INTELLIGENCE; ASPIRIN; ASTHMA; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-1 TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 66749090518     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2009.03229.x     Document Type: Article

References (33)

1. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999 104 : 5 13. (Pubitemid 29364472)
2. Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 2006 118 : 773 86.
3. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on aspirin-induced asthma. Eur Respir J 2000 16 : 432 6.
4. Sanak M, Simon HU, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 1997 350 : 1599 600.
5. 4 synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol 2000 23 : 290 6.
6. Choi JH, Park HS, Oh HB et al. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet 2004 114 : 337 44.
7. 2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. Hum Mol Genet 2004 13 : 3203 17.
8. 2 receptor subtype EP3 gene (Ptger3) and asthma in the Korean population. Clin Exp Allergy 2007 37 : 1609 15.
9. Nakatani N, Hattori E, Ohnishi T et al. Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Hum Mol Genet 2006 15 : 1949 62.
10. Okada H, Tajima A, Shichiri K, Tanaka A, Tanaka K, Inoue I. Genome-wide expression of azoospermia testes demonstrates a specific profile and implicates ART3 in genetic susceptibility. PLoS Genet 2008 4 : e26.
11. Meltzer EO, Hamilos DL, Hadley JA et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004 114 : S155 212. (Pubitemid 39575875)
12. Yoshifuku K, Matsune S, Ohori J, Sagara Y, Fukuiwa T, Kurono Y. IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration. Rhinology 2007 45 : 235 41.
13. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004 328 : 434.
14. Pleskow WW, Stevenson DD, Mathison DA, Simon RA, Schatz M, Zeiger RS. Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin. J Allergy Clin Immunol 1983 71 : 574 9.
15. National Heart, Lung and Blood Institute. Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert panel report. J Allergy Clin Immunol 1991 88 : 425 534.
16. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testings. J R Statist Soc B 1995 57 : 289 300.
17. Slonim DK. From patterns to pathways: gene expression data analysis comes of age. Nat Genet 2002 32 (Suppl.) : 502 8.
18. Dennis G Jr., Sherman BT, Hosack DA et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003 4 : P3.
19. Churchill GA, Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics 1994 138 : 963 71.
20. -ΔΔCT method. Methods 2001 25 : 402 8.
21. Hill WG, Robertson A. Linkage disequilibrium in finite populations. Theor Appl Genet 1968 38 : 226 31.
22. Lewontin RC. The interaction of selection and linkage. I. General considerations; Heterotic models. Genetics 1964 49 : 49 67.
23. Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003 19 : 149 50.
24. 4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998 101 : 834 46.
25. Tavazoie S, Hughes JD, Campbell MJ, Cho RJ, Church GM. Systematic determination of genetic network architecture. Nat Genet 1999 22 : 281 5.
26. Mellor AL, Munn DH. Extinguishing maternal immune responses during pregnancy: implications for immunosuppression. Semin Immunol 2001 13 : 213 8.
27. Babcock TA, Carlin JM. Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells. Cytokine 2000 12 : 588 94.
28. Yuan W, Collado-Hidalgo A, Yufit T, Taylor M, Varga J. Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression. J Cell Physiol 1998 177 : 174 86.
29. MacKenzie CR, González RG, Kniep E, Roch S, Däubener W. Cytokine mediated regulation of interferon-gamma-induced IDO activation. Adv Exp Med Biol 1999 467 : 533 9.
30. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999 189 : 1363 72.
31. Schroecksnadel K, Winkler C, Wirleitner B, Schennach H, Fuchs D. Aspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro. Clin Exp Immunol 2005 140 : 41 5.
32. Colotta F, Re F, Muzio M et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993 261 : 472 5.
33. Porreca E, Reale M, Di Febbo C et al. Down-regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. Immunology 1996 89 : 424 9.